Analysts' Actions: AH, CPN, ERTS
NEW YORK (
) --
CHANGE IN RATINGS
Accretive Health
(AH)
was upgraded from Perform to Outperform at Oppenheimer. $31 price target. Well-positioned to meet or exceed revenue expectations for 2012, Oppenheimer said.
AIMCO
(AIV) - Get Report
was upgraded at UBS from Sell to Neutral. $21 price target. Waning demand trends are priced into shares, UBS said.
Calpine
(CPN)
was downgraded at Jefferies from Buy to Hold. $15 price target. Weakened price forecasts for gas and power, Jefferies said.
Electronic Arts
( ERTS) was upgraded at Citigroup from Neutral to Buy. $26 price target. Valuation call, Citigroup said.
McDermott
(MDR) - Get Report
was initiated with a Buy rating at Stifel Nicolaus. $16 price target. Company is seeing a solid pricing environment, Stifel Nicolaus said.
Navistar
(NAV) - Get Report
was upgraded at Goldman Sachs from Sell to Neutral. Valuation call, based on a $38 price target, Goldman said.
Netflix
(NFLX) - Get Report
was downgraded at Wedbush Securities from Neutral to Underperform. $45 price target. Company continues to face higher content costs, Wedbush said.
OneBeacon Insurance
(OB)
was upgraded to Buy at TheStreet Ratings.
Rada Electronics Industries
(RADA) - Get Report
was downgraded to Sell at TheStreet Ratings.
Transocean
(RIG) - Get Report
was downgraded at Argus Research from Buy to Hold. Company had a weak November fleet report, and the share raise will dilute earnings, Argus said.
Vulcan Materials
(VMC) - Get Report
was downgraded at Goldman Sachs to Sell. $29 price target. Company could face excess capacity in concrete and asphalt mix, Goldman said. $29 price target.
STOCK COMMENTS / EPS CHANGES
Avago Technologies
(AVGO) - Get Report
numbers were adusted at Citigroup. Shares are now seen reaching $41. Estimates were lowered as industrial creates N/T Rev/GM headwinds, Citigroup said. Buy rating.
Copart
(CPRT) - Get Report
estimates, target were raised at ThinkEquity. Shares are now seen reaching $48. Estimates were also increased, as the company is investing into potential future growth, ThinkEquity said. Hold rating.
Corning
(GLW) - Get Report
estimates were reduced at Morgan Stanley through 2013. Company is seeing lower demand for its gorilla glass, Morgan Stanley said. Equal-weight rating.
Corning estimates, target lowered at UBS. Shares are now seen reaching $17. Estimates were also decreased as Gorilla guided down 25% on weak tablet demand, UBS said. Buy rating.
Corning estimates, target lowered at Citigroup. Shares are now seen reaching $14, according to Citigroup. Estimates also lowered on another negative pre-announcement.
Home Depot
(HD) - Get Report
estimates, target were increased at UBS. Shares are now seen reaching $45. Estimates were also increased on upbeat assessment of both its near-term and longer-term outlooks. Buy rating.
Northeast Utilities
(NU)
numbers were increased at UBS. Shares are now seen reaching $35. Estimates were also increased on recent group moves, UBS said. Neutral rating.
Transocean
(RIG) - Get Report
estimates, target were cut at Guggenheim Securities. Shares of RIG are now seen reaching $50. Estimates were also cut, given higher operating costs and dilution from the recent stock offering, Guggenheim said. Neutral rating.
Transocean estimates, target lowered at UBS. Shares are now seen reaching $62. Estimates also lowered as liquidity crunch drives equity deal, UBS said. Buy rating.
Semtech Corporation
(SMTC) - Get Report
estimates were lowered at Oppenheimer through 2013. The overall demand environment remains challenged, Oppenheimer said. Outperform rating.
UnitedHealth Group
(UNH) - Get Report
estimates were raised at UBS through 2012. $58 price target. Commercial outlook appears conservative, UBS said. Buy rating.
UnitedHealth Group numbers were raised at Jefferies. Shares are now seen reaching $60. Estimates were also raised on upbeat investor day, Jefferies said. Buy rating.
>To submit a news tip, email:
.
RELATED STORIES:
>>Stocks to Watch: Goldman, Pfizer, Omnivision
>>Facebook Privacy, Google Maps: Hot Trends
Follow
TheStreet
on
and become a fan on
This article was written by a staff member of RealMoney.com.
